Specifically, the invention relates to the discovery and development of an effective cryogenic gastrointestinal triggering device that artificially activates the gastrointestinal tract's involuntary intestinal functions in the application process. Generally, several of the invention's functions relates to a method for decreasing undesirable bacteria in the intestinal tract for achieving a healthy glucose and insulin regulation, inclusive intestinal and body health, and metabolic fitness. The invention has both human and animal application.
